Catabasis Pharmaceuticals' Series A Round

Catabasis Pharmaceuticals raised a round of funding on April 21, 2010.

Catabasis is a clinical stage biotechnology company with a robust portfolio of investigational new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases. The company's dru…

Articles about Catabasis Pharmaceuticals' Series A Round: